Mexico In Vitro Diagnostics Market Size & Growth Report 2031

Mexico In Vitro Diagnostics Market Size & Growth Report 2031

Segments - Mexico In-Vitro Diagnostics Market by Utilization (Disposable IVD Devices and Reusable IVD Devices), Product (Instrument, Reagent, and Others), and Country (Mexico) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023-2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2401 | 4.3 Rating | 61 Reviews | 189 Pages | Format : PDF Excel PPT

Report Description


Mexico In-Vitro Diagnostics Market Outlook 2031:

The Mexico in-vitro diagnostics market size was valued at USD 10.21 Billion in 2022 and is projected to reach USD 17.10 Billion by 2031, expanding at a CAGR of 5.9% during the forecast period 2023 - 2031. Growth of the market is attributed to increasing population, advancement in genetics, and enhanced efficiency of in-vitro diagnostics in diagnosis of cancer.

Mexico In-Vitro Diagnostics Market Outlook

In vitro diagnostics are tests done on tissue and blood samples of the human body. In vitro diagnostics can monitor patient’s health and discover other conditions to help them treat, cure, and prevent diseases.

The Covid-19 pandemic affected the demand and supply of Mexico in-vitro diagnostics market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

  • Increasing product launches with advanced features is projected to boost the market in the coming years.
  • Increasing awareness about environmental concerns is the major factor fueling the market in coming years.
  • Decrease in adaptation rate of in-vitro diagnostics is anticipated to restrict the market growth.
  • Stringent regulatory guidelines and reimbursement policies are projected to hamper the market expansion.
  • R&D investment and technological advancement in in vitro diagnostics is projected to create lucrative opportunities for the market players.

Scope of the In-Vitro Diagnostics Market Report

The report on the Mexico in-vitro diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Mexico In-vitro Diagnostics Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Utilization (Disposable IVD Devices and Reusable IVD Devices), Product (Instrument, Reagent, and Others)

Country Scope

Mexico

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

BioMerieux, Bio-Rad Laboratories, Inc., Sysmex Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc.

In-Vitro Diagnostics Market Segment Insights:

The reusable IVD devices segment accounts for a major share of the market

Based on utilization, the Mexico in-vitro diagnostics market is segregated into disposable IVD devices and reusable IVD devices. The reusable IVD devices segment accounts for a major share of the market.

Growth of the market is attributed to increasing demand of in-vitro toxicology testing in pharmaceuticals sector and increasing advancement in genetics. The disposable IVD devices segment is anticipated to expand at a rapid pace during the forecast period due to factors such as rising prevalence of diabetes disease and rapid technological advancement in in-vitro toxicology testing methods.

Mexico In-Vitro Diagnostics Market Utilization

The reagent segment accounts for a significant share of the market

On the basis of product, the Mexico in-vitro diagnostics market is segregated into instrument, reagent, and others. The reagent segment accounts for a significant share of the market. Growth of the market is attributed to well-established healthcare infrastructure and increasing healthcare expenditure.

The instrument segment is anticipated to expand at a rapid pace during the forecast period due to rapid adoption of point of care testing.

Mexico In-Vitro Diagnostics Market Products

Segments

The Mexico in-vitro diagnostics market is segmented on the basis of

Utilization

  • Disposable IVD Devices
  • Reusable IVD Devices

Product

  • Instrument
  • Reagent
  • Others

Country

  • Mexico

Key Players

Competitive Landscape

Key players competing in the Mexico in-vitro diagnostics market include BioMerieux, Bio-Rad Laboratories, Inc., Sysmex Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc.

Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming year.

Mexico In-Vitro Diagnostics Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In-Vitro Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. In-Vitro Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. In-Vitro Diagnostics Market - Supply Chain
  4.5. Global In-Vitro Diagnostics Market Forecast
     4.5.1. In-Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. In-Vitro Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. In-Vitro Diagnostics Market Absolute $ Opportunity
5. Global In-Vitro Diagnostics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. In-Vitro Diagnostics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global In-Vitro Diagnostics Demand Share Forecast, 2019-2026
6. North America In-Vitro Diagnostics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America In-Vitro Diagnostics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America In-Vitro Diagnostics Demand Share Forecast, 2019-2026
7. Latin America In-Vitro Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America In-Vitro Diagnostics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America In-Vitro Diagnostics Demand Share Forecast, 2019-2026
8. Europe In-Vitro Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe In-Vitro Diagnostics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe In-Vitro Diagnostics Demand Share Forecast, 2019-2026
9. Asia Pacific In-Vitro Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific In-Vitro Diagnostics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific In-Vitro Diagnostics Demand Share Forecast, 2019-2026
10. Middle East & Africa In-Vitro Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa In-Vitro Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa In-Vitro Diagnostics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global In-Vitro Diagnostics Market: Market Share Analysis
  11.2. In-Vitro Diagnostics Distributors and Customers
  11.3. In-Vitro Diagnostics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. BioMerieux
     11.4.2. Bio-Rad Laboratories, Inc.
     11.4.3. Sysmex Corporation
     11.4.4. Abbott Laboratories
     11.4.5. Thermo Fisher Scientific Inc.

Methodology

Our Clients

Honda Motor Co. Ltd.
The John Holland Group
Pfizer
sinopec
Microsoft
Dassault Aviation
General Mills
Deloitte